Summary of the 2021 annual report and 2022 first quarter report of the medical sector of Sinolink Securities: The overall performance is clear, and it still maintains a strong growth ability! -Funds Financial Sector

  • Post date May 5, 2022 — 16:30 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 000963 002030 002289 002786 002821 300015 300143 300170 300198 300244 300253 300298 300322 300347 300363 300376 300482 300529 300713 300759 300760 300832 Aier Eye Hospital Group Asymchem Laboratories (Tianjin) Beijing Wantai Biological Pharmacy Enterprise Bloomage Biotechnology Corporation Limited Da An Gene Of Sun Yat-Sen University Dian Diagnostics Group Guangzhou Kingmed Diagnostics Group Guangzhou Wondfo Biotech Hangzhou Tigermed Consulting Huadong Medicine Inkon Life Technology Jafron Biomedical Joinn Laboratories Pharmaron Beijing Porton Pharma Solutions Qingdao Haier Biomedical Shanghai Haohai Biological Technology Shanghai Medicilon Shanghai Microport Endovascular Medtech Sinocare Sinolink Securities Topchoice Medical Inc Winning Health Technology Group Wuxi Apptec Zhejiang Orient Gene Biotech Arts, Culture, Entertainment, Media Conflict, War, Peace War Earnings Strategy, Marketing Annual, Special Corporate Meeting Annual Report Patent, Copyright, Trademark Research, Development Health, Beauty Product Pharmaceutical Financial, Business Service Insurance Media Consumers Market, Exchange Securities Stocks Diseases, Conditions Epidemic Hospital Medical Equipment Pet Product, Service Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data